upadacitinib

tumor necrosis factor ; Homo sapiens







3 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 35189270 Upadacitinib protects against cisplatin-induced renal and hepatic dysfunction without impairing its anticancer activity. 2022 May 1 1
2 34042156 Randomized Controlled Trial Substudy of Cell-specific Mechanisms of Janus Kinase 1 Inhibition With Upadacitinib in the Crohn's Disease Intestinal Mucosa: Analysis From the CELEST Study. 2021 Nov 15 1
3 34937767 Efficacy of biological therapies and small molecules in moderate to severe ulcerative colitis: systematic review and network meta-analysis. 2021 Dec 22 2